How can dendritic cells cause autoimmune disease?

Immunology Today

Volumn 21, Issue 5, 2000, Pages 214-217

  Drakesmith, Hal ^a   Chain, Benjamin ^b   Beverley, Peter ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; DENDRITIC CELL; GENE MUTATION; GENETIC REGULATION; HUMAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE;

EID: 0034020702     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01610-8     Document Type: Note

References (43)

1. Houssiau F.A.et al. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis. Rheum. 31:1988;784-788.
2. de Benedetti F.et al. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis. Rheum. 34:1991;1158-1163.
3. Brennan F.M., Feldmann M. Cytokines in autoimmunity. Curr. Opin. Immunol. 8:1996;872-877.
4. van Oosten B.W.et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47:1996;1531-1534.
5. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
6. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
7. Sallusto F.et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:1995;389-400.
8. Sercarz E.E.et al. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:1993;729-766.
9. Guery J.C.et al. Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J. Exp. Med. 183:1996;751-757.
10. Guery J.C., Adorini L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol. 154:1995;536-544.
11. Inaba K.et al. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:1997;665-672.
12. de Vere Tyndall A.et al. Veiled (dendritic) cells in synovial fluid. Lancet. i:1983;472-473.
13. Harding B., Knight S.C. The distribution of dendritic cells in the synovial fluids of patients with arthritis. Clin. Exp. Immunol. 63:1986;594-600.
14. Huang Y.M.et al. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 99:1999;82-90.
15. Ludewig B.et al. Dendritic cells induce autoimmune disease and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188:1998;1493-1501.
16. Dittel B.N.et al. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163:1999;32-39.
17. Anderson D.M.et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-179.
18. Cella M.et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:1996;747-752.
19. Heufler C.et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 26:1996;659-668.
20. Kalinski P.et al. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159:1997;28-35.
21. Steinbrink K.et al. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:1997;4772-4780.
22. de St Groth B.F. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today. 19:1998;448-454.
23. Rissoan M.C.et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283:1999;1183-1186.
24. Shinomiya M.et al. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 117:1999;38-43.
25. Frosch S.et al. The capacity of bone marrow-derived macrophages to process bovine insulin is regulated by lymphokines. Int. Immunol. 5:1993;1551-1558.
26. Drakesmith H.et al. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin-6 and native antigen. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14903-14908.
27. Takahashi K.et al. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J. Immunol. 161:1998;2629-2635.
28. Delemarre F.G.et al. Signs of immaturity of splenic dendritic cells from the autoimmune prone biobreeding rat: consequences for the in vitro expansion of regulator and effector T cells. J. Immunol. 162:1999;1795-1801.
29. Binks M.et al. Intrinsic dendritic cell abnormalities in Wiscott-Aldrich syndrome. Eur. J. Immunol. 28:1998;3259-3267.
30. Wang J.et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 98:1999;47-58.
31. Crawley E.et al. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis. Rheum. 42:1999;1101-1108.
32. Ohshima S.et al. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8222-8226.
33. Alonzi T.et al. Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:1998;461-468.
34. Eugster H.P.et al. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;2178-2187.
35. Mendel I.et al. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1998;1727-1737.
36. Okuda Y.et al. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:1998;703-708.
37. Samoilova E.B.et al. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:1998;6480-6486.
38. Richards H.B.et al. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188:1998;985-990.
39. Frei K.et al. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
40. Liu J.et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
41. Schreyer S.A.et al. Obesity and diabetes in TNF-alpha receptor-deficient mice. J. Clin. Invest. 102:1998;402-411.
42. Ferber I.A.et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
43. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.